California Public Employees Retirement System
ALXN

California Public Employees Retirement System’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-949,278
Closed -$174M 1556
2021
Q2
$174M Buy
949,278
+429,040
+82% +$78.8M 0.13% 162
2021
Q1
$79.6M Sell
520,238
-15,465
-3% -$2.36M 0.06% 315
2020
Q4
$83.7M Buy
535,703
+28,550
+6% +$4.46M 0.06% 291
2020
Q3
$58M Buy
507,153
+18,452
+4% +$2.11M 0.05% 333
2020
Q2
$54.9M Buy
488,701
+2,781
+0.6% +$312K 0.05% 336
2020
Q1
$43.6M Sell
485,920
-34,053
-7% -$3.06M 0.05% 328
2019
Q4
$56.2M Buy
519,973
+50,118
+11% +$5.42M 0.05% 367
2019
Q3
$46M Buy
469,855
+113,287
+32% +$11.1M 0.05% 372
2019
Q2
$46.7M Buy
356,568
+2,733
+0.8% +$358K 0.06% 337
2019
Q1
$47.8M Sell
353,835
-19,077
-5% -$2.58M 0.06% 345
2018
Q4
$36.3M Sell
372,912
-67,966
-15% -$6.62M 0.05% 377
2018
Q3
$61.3M Sell
440,878
-44,149
-9% -$6.14M 0.08% 252
2018
Q2
$60.2M Sell
485,027
-41,542
-8% -$5.16M 0.08% 234
2018
Q1
$58.7M Sell
526,569
-27,473
-5% -$3.06M 0.08% 236
2017
Q4
$66.3M Buy
554,042
+90,463
+20% +$10.8M 0.09% 227
2017
Q3
$65M Buy
463,579
+15,588
+3% +$2.19M 0.1% 208
2017
Q2
$54.5M Buy
447,991
+9,300
+2% +$1.13M 0.09% 233
2017
Q1
$53.2M Sell
438,691
-18,300
-4% -$2.22M 0.09% 233
2016
Q4
$55.9M Sell
456,991
-31,600
-6% -$3.87M 0.09% 218
2016
Q3
$59.9M Sell
488,591
-31,800
-6% -$3.9M 0.1% 210
2016
Q2
$60.8M Sell
520,391
-23,400
-4% -$2.73M 0.1% 215
2016
Q1
$75.7M Sell
543,791
-35,100
-6% -$4.89M 0.12% 156
2015
Q4
$110M Sell
578,891
-1,700
-0.3% -$324K 0.17% 115
2015
Q3
$90.8M Buy
580,591
+13,699
+2% +$2.14M 0.15% 129
2015
Q2
$102M Sell
566,892
-48,192
-8% -$8.71M 0.15% 125
2015
Q1
$111M Hold
615,084
0.15% 133
2014
Q4
$111M Buy
615,084
+16,116
+3% +$2.91M 0.15% 133
2014
Q3
$99.3M Sell
598,968
-30,341
-5% -$5.03M 0.14% 149
2014
Q2
$98.3M Sell
629,309
-127,745
-17% -$20M 0.13% 156
2014
Q1
$112M Buy
757,054
+54,425
+8% +$8.04M 0.16% 125
2013
Q4
$93.4M Buy
702,629
+175,304
+33% +$23.3M 0.14% 146
2013
Q3
$61.3M Buy
527,325
+6,220
+1% +$723K 0.11% 169
2013
Q2
$48.1M Buy
+521,105
New +$48.1M 0.1% 208